<DOC>
	<DOCNO>NCT00152971</DOCNO>
	<brief_summary>To determine comparative efficacy safety two different dos ( 75mg day 1 follow 150 mg day 2-completion , 110 mg day 1 follow 220 mg day 2-completion ) dabigatran administer orally ( capsule ) , compare enoxaparin 30 mg twice day subcutaneous , prevention venous thromboembolism patient primary elective total knee replacement surgery</brief_summary>
	<brief_title>Dabigatran Etexilate v Enoxaparin Prevention Venous Thromboembolism ( VTE ) Post Total Knee Replacement</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<criteria>Inclusion criterion INCLUSION CRITERIA 1 . Patients schedule undergo primary , unilateral elective total knee repla cement . 2 . Male female 18 year age old . 3 . Patients weigh least 40 kg . 4 . Written inform consent prior start study participation . Exclusion criterion EXCLUSION CRITERIA 1 . History bleed diathesis . 2 . Constitutional acquire coagulation disorder investigator 's judgment put patient excessive risk bleeding . 3 . Major surgery trauma ( e.g . hip fracture ) within last 3 month . 4 . Recent unstable cardiovascular disease , uncontrolled hypertension time enrollment ( investigator 's judgment ) history myocardial infarction within last 3 month . 5 . Spinal epidural anesthesia , 3 attempt ( stick ) placement make , placement traumatic . Please note patient , exclude criterion , catheter pull completion surgery . 6 . Any history hemorrhagic stroke follow intracranial pathology : bleeding , neoplasm , arteriovenous ( AV ) malformation aneurysm . 7 . History VTE preexist condition require anticoagulant therapy . 8 . Clinically relevant bleeding ( e.g . gastrointestinal , pulmonary , intraocular urogenital bleeding ) within last 6 month . 9 . Gastric duodenal ulcer within last 6 month . 10 . Liver disease expect potential impact survival ( e.g . hepatitis B C , cirrhosis , Gilbert 's syndrome hepatitis A complete recovery ) . 11 . Elevated AST ALT &gt; 2x upper limit normal , base central lab result local lab result within 1 month enrollment . 12 . Known severe renal insufficiency ( CrCl &lt; 30 mL/min ) . In order determine patient inclusion/exclusion , creatinine clearance ( CrCl ) need calculated serum creatinine elevate renal insufficiency suspect .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>